Respiratory Motion Obtains $5,800,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3afdd371-51ea-45e2-9499-ed6545d6f694
Date
2/27/2014
Company Name
Respiratory Motion
Mailing Address
411 Waverly Oaks Rd. Waltham, MA 02452
Company Description
Respiratory Motion, Inc. (RMI) is a new generation medical device company developing and commercializing the ExSpironTM. RMI’s goal is to cost-effectively improve the standard of care in respiration monitoring. Ventilation monitoring is increasingly recommended as oxygen saturation levels inadequately predict ventilatory distress.
Website
http://www.respiratorymotion.com
Transaction Type
Venture Equity
Transaction Amount
$5,800,000
Transaction Round
Series B
Proceeds Purposes
The funds raised will support sales and marketing of the Company’s innovative ExSpiron respiration monitoring system.
M&A Terms
Venture Investor
Easton Capital
Venture Investor
Undisclosed